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ABSTRACT
The human DEK gene is frequently overexpressed and
sometimes amplified in human cancer. Consistent
with oncogenic functions, Dek knockout mice are
partially resistant to chemically induced papilloma
formation. Additionally, DEK knockdown invitro sen-
sitizes cancer cells to DNA damaging agents and
induces cell death via p53-dependent and -inde-
pendent mechanisms. Here we report that DEK is
important for DNA double-strand break repair. DEK
depletion in human cancer cell lines and xenografts
was sufficient to induce a DNA damage response as
assessed by detection of cH2AX and FANCD2.
Phosphorylation of H2AX was accompanied by con-
trasting activation and suppression, respectively,
of the ATM and DNA-PK pathways. Similar DNA
damage responses were observed in primary Dek
knockout mouse embryonic fibroblasts (MEFs),
along with increased levels of DNA damage and ex-
aggerated induction of senescence in response to
genotoxic stress. Importantly, Dek knockout MEFs
exhibited distinct defects in non-homologous end
joining (NHEJ) when compared to their wild-type
counterparts. Taken together, the data demonstrate
new molecular links between DEK and DNA damage
response signaling pathways, and suggest that DEK
contributes to DNA repair.
INTRODUCTION
The human Dek oncogene was ﬁrst discovered as a fusion
with the gene encoding the CAN nucleoporin protein,
NUP214, in a subset of acute myeloid leukemia (AML)
patients (1). Apart from its original association with
cancer as a fusion protein, upregulated DEK expression
has also been linked to various solid human tumors, as
well as AML types that do not exhibit the above trans-
location (2–10). We previously reported that DEK
overexpression promotes the transformation of human
keratinocytes, and that Dek knockout mice are partially
resistant to chemically induced papilloma formation
(11,39). The overexpression of DEK inhibits cell death,
and its knockdown results in apoptosis in HeLa cells
and primary keratinocytes, in part through the stabiliza-
tion and transcriptional activation of p53 (12,40). Other
reports similarly are consistent with a role for DEK in
cellular survival (13,14). Together, these ﬁndings support
a role for DEK as an oncogene. The underlying molecular
mechanisms by which it functions, however, remain
poorly understood.
DEK is a highly abundant, evolutionarily conserved
and ubiquitous nuclear protein that can be regulated at
the level of transcription and post-translational modiﬁca-
tions (15–21). Evidence suggests that it may function as a
nuclear architectural protein. Similar to the classical chro-
matin architectural high mobility group (HMG) proteins,
DEK contains regions enriched in acidic amino acids
(22,23) and preferentially binds to supercoiled and
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erature supports distinct intracellular functions for DEK
in DNA replication (25), positive and negative regulation
of gene transcription (26–30), histone acetylation (31,32),
mRNA splicing (20,33) and nucleosome assembly (34).
Several reports have already suggested that DEK may
modulate genome stability. First, a C-terminal fragment
of DEK could partially rescue Ataxia–Telangiectasia
(A–T) ﬁbroblast mutagen sensitivity, high spontaneous
recombination rates, and radio-resistant DNA synthesis
(35). Second, DEK knockdown sensitized HeLa cells to
genotoxic stress (18) and resulted in chemosensitivity to
doxorubicin in melanoma cells (14). Accordingly, we hypo-
thesized that DEK expression is important for DNA
damage sensing and/or repair.
Sustaining DNA integrity is a continuous cellular chal-
lenge in the face of endogenous and exogenous DNA
damage insults. Sensor kinases detect damage and signal
the appropriate cellular responses. Proper repair of a
lesion is followed by the resumption of normal cellular
proliferation and continued growth, whereas incomplete
repair results in prolonged cell-cycle arrest and ultimately,
cell death. The protein kinase ataxia telangiectasia
mutated (ATM) undergoes autophosphorylation on
Ser1981 in response to DNA double-strand breaks
(DSBs), and then phosphorylates and activates down-
stream targets including structural maintenance of
chromosomes 1 (SMC1) (36,37). The DNA-dependent
protein kinase (DNA-PK), which is composed of the
Ku70/80 heterodimer and the DNA-PK catalytic subunit
(DNA-PKcs), responds to DSBs by the initial recruitment
of Ku70/80, binding and autophosphorylation of
DNA-PKcs, and subsequent recruitment of the DNA
repair machinery. The most extensively studied types of
DSB DNA repair are homologous recombination (HR)
and non-homologous end joining (NHEJ). HR utilizes
the ATM pathway proteins and homologous DNA se-
quences as a template for DNA repair, while NHEJ
fuses broken ends of DNA with little regard for
homology (38).
Here we demonstrate that the loss of DEK expression,
either by knock-down in human cells or by genetic deletion
in murine cells, is sufﬁcient to activate the DNA damage
response and to exaggerate phenotypic responses to ex-
ogenous stress. DEK loss results in stimulated ATM
activity, attenuated Ku70/80 recruitment, and repressed
DNA-PK activity, in correlation with a decrease in
repair by NHEJ. Together, these data suggest that DEK
expression modulates ATM and DNA-PK signaling and
the efﬁciency of DNA DSB repair.
MATERIALS AND METHODS
Cell culture
U2OS human osteosarcoma and HeLa cervical cancer cell
lines (ATCC, Manassas, VA, USA) were maintained in
Dulbecco’s modiﬁed Eagle medium (DMEM) (Sigma,
St. Louis, MO, USA) supplemented with 10% fetal
bovine serum (FBS) and antibiotics. The SAOS-2 human
osteosarcoma cell line (ATCC) was maintained in
McCoy’s 5a modiﬁed medium (ATCC) with 15% FBS
andantibiotics. Dekwild-type, heterozygousandknockout
mice [described in (39)] were used to generate MEFs.
MEFs from Day 13.5 embryos were explanted and main-
tained in high glucose DMEM containing 10% FBS,
2mM L-glutamine, 100mM MEM non-essential amino
acids, 0.055mM b-mercaptoethanol and 10mg/ml gent-
amycin. Immortalized MEFs were obtained by 3T3
serial passaging. Cells were treated with 1mM hydroxy-
urea, 1mM camptothecin and 4mMo r2 5 mM etoposide
for indicated periods of time (all from Sigma) or with
10Gy g-irradiation (IR) and collected post-treatment at
the indicated times.
Plasmids and viral constructs
Ad-GFP and AdDEKsh adenoviruses were described pre-
viously (40). Retroviral R780 and R780-DEK expression
vectors were described previously, with the exception that
vector particles were Eco pseudotyped (11).
Adenoviral and retroviral infections
For adenoviral infections, cells were infected as previously
published, using 10 infectious units per cell (40). For retro-
viral infections, cells were incubated with virus for 4h in
medium containing 2mg/ml polybrene, then washed and
overlaid with fresh medium. Retrovirally infected cells
were sorted for GFP and expanded as a polyclonal
population.
Western blot analyses
Whole cell lysates were harvested with RIPA buffer con-
taining phosphatase inhibitors and analyzed as described
previously (40). For detection of DNA damage re-
sponse proteins, cells were lysed in 50mM Tris–HCl,
pH 7.4, 250mM NaCl and 5mM EGTA, supplemented
with protease and phosphatase inhibitors (BD
Biosciences, San Jose, CA, USA). Primary antibodies:
DEK (1:1000; BD Biosciences, San Diego, CA, USA),
gH2AX (1:1000; Upstate, Charlottesville, VA, USA);
p53ser15 (1:1000; Santa Cruz Biotechnologies, Santa
Cruz, CA, USA), DNA-PKcs (1:500; Santa Cruz),
phospho-ATM (Ser1981) (1:1000; R&D, Minneapolis,
MN, USA), ATM (1:1000; Cell Signaling, Boston, MA,
USA), phospho-SMC1 (Ser957) (1:1000; Cell Signaling),
SMC1 (1:1000; Abcam, Cambridge, MA, USA),
phospho-DNA-PKcs (Ser2056) (1:500; Abcam); and
actin (1:20,000; a gift from James Lessard, Cincinnati
Children’s Hospital Medical Center, Cincinnati, OH,
USA). Membranes were exposed to enhanced chemilu-
minescence reagents (Perkin Elmer, Boston, MA, USA)
and bands detected by chemiluminescence. Band
intensities were quantiﬁed using ImageJ software, and
ﬁrst normalized to actin in each case, and then expressed
as fold change for AdDEKsh relative to Ad-GFP control
sample. FANCD2 monoubiquitination was expressed as
the intensity of the monoubiquitinated (L, long) relative to
the non-ubiquitinated (S, short) form of the protein.
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For DEK depletion in xenograft tumors, 1 10
6 U2OS
cells were injected into each ﬂank of 4- to 8-week-old fe-
male athymic nude mice (Harlan Laboratories,
Indianapolis, IN, USA). Tumors were allowed to grow
to 150–250mm
3, and 10
8 infectious units of Ad-GFP or
AdDEKsh were injected into tumors on the left and right
ﬂank, respectively (39). Tumors were virally injected on
Days 0, 3 and 6, and harvested 24h later. Tumor tissue
was ﬁxed in 4% paraformaldehyde, washed with PBS, and
gradually dehydrated in 50% and 70% ethanol for
parafﬁn embedding.
Immunoﬂuorescence microscopy
Cells were plated onto 100mg/ml poly-D-lysine hydrobro-
mide (Sigma) coated coverslips, infected with Ad-GFP or
AdDEKsh adenoviruses, and ﬁxed with 2% paraform-
aldehyde. Coverslips were incubated in 0.2% Triton
X-100 for 3min, blocked with 5% normal goat serum,
and incubated with primary antibody for 1h at 37 C.
Antibody dilutions were as follows: DEK (1:20; BD
Biosciences); gH2AX (1:1000; Upstate); FANCD2
(1:1000; Novus, Littleton, CO, USA); and SC35 (1:2000;
Sigma). Coverslips were incubated in secondary anti-
mouse or anti-rabbit rhodamine- or FITC-conjugated
antibody (1:200; Jackson Immunoresearch, West Grove,
PA, USA) for 30min at 37 C, and mounted onto glass
slides with DAPI Vector Vectashield mounting media
(Vector Laboratories, Burlingame, CA, USA). For im-
munoﬂuorescence analysis of Ku70/80 dimer mobiliza-
tion, we utilized heterodimer-speciﬁc anti-Ku70/80
antibody (clone 162) (1:300; Abcam), following estab-
lished methodologies (41). Subsequent detection was
with secondary anti-mouse rhodamine-conjugated
antibody (1:200, Jackson Immunoresearch). For analysis
of tumor sections, eight micron sections from parafﬁn
embedded tissue were deparafﬁnized and sequentially
rehydrated. Sections were boiled in 10mM sodium citrate
buffer for 20min, washed in PBS, blocked for 1h, and
incubated in GFP primary antibody (1:200; Abcam) for
1h. Following washes, sections were incubated in anti-
rabbit FITC-conjugated secondary antibody for 30min
at room temperature, and mounted using Vector
Vectashield mounting medium. Images in Figure 1 were
taken using  100 magniﬁcation on a Zeiss ﬂuorescence
microscope (Zeiss, Thornwood, NY, USA) with an
Axiovision camera (Lucas Microscope Service, Skokie,
IL) driven by Axiovision software. Images in Figure 3
were taken using  100 magniﬁcation on a Zeiss LSM
510 laser scanning confocal microscope using LSM510
and Zen software.
Immunohistochemistry
Sections were prepared as described above. For analysis of
gH2AX, samples were blocked in M.O.M mouse IgG
(Vector Laboratories) and incubated in gH2AX primary
antibody (1:1000; Upstate) for 1h. Following washes,
sections were incubated with biotinylated secondary
antibody for 30min. Staining was developed in 3,30
diaminobenzidine solution (Vector Laboratories) for
2–4min and counterstained with Nuclear fast Red
(Biomeda, Foster City, CA, USA). Sections were
dehydrated in ethanol followed by xylene, and mounted
with Permount (Fisher Scientiﬁc, Suwanee, GA, USA).
Alkaline comet assays
HeLa cells were infected with Ad-GFP and AdDEKsh
adenoviruses, and MEFs were treated with 1mM hydro-
xyurea for 24h. Detection of both single and double
strand DNA breaks was determined using the Trevigen
CometAssay Kit (Trevigen, Gaithersburg, MD, USA)
per the manufacturer’s instructions. Images were captured
using  20 magniﬁcation on a Zeiss ﬂuorescence micro-
scope with an Axiovision camera driven by Axiovision
software. Images were saved as bitmap ﬁles and tail
moments calculated using TriTek CometScore
TM
Freeware v1.5.
DNA-PK kinase assays
HeLa cells were infected with Ad-GFP or AdDEKsh, and
nuclear extracts prepared Day 3 post-infection as previ-
ously described (42). Nuclear extracts were run through
1ml DEAE Sepharose columns (GE Healthcare,
Piscataway, NJ, USA) to remove endogenous DNA
using an AKTApuriﬁer (GE Healthcare). The nuclear ex-
tracts were then used for kinase assays to determine
DNA-PK activity according to manufacturer’s protocol
(Promega, Madison, WI, USA). DNA-PK enzyme
activity (in pmol ATP/min/mg of protein) was determined
using the following equation: [(cpmreaction with activator 
cpmreaction without activator) reaction volume]/[(volume
reaction inml on membrane) (timemin) (mg protein in
reaction) (speciﬁc activity of [g-
32P] ATP).
BrdU incorporation and cell-cycle analysis by ﬂow
cytometry
Primary MEFs grown to 70–80% conﬂuency in 10cm
plates were pulsed with 10mM BrdU for 45min before
collection by trypsinization, prepared using the BD
Pharmingen APC BrdU Flow Kit per the manufacturer’s
instructions and as previously published (40), and
analyzed on a BD FacsCalibur (BD Biosciences).
Drug sensitivity assay
One hundred thousand primary wild-type and Dek
knockout MEFs were plated in six-well plates in
medium only or medium containing 4mM etoposide, which
was replenished every 24h. Attached cells were trypsinized
and counted at 4h for plating efﬁciency and at 24, 72 and
120h post-plating for cell numbers. Additionally, cells
were ﬁxed and stained for SA-b-galactosidase to deter-
mine levels of senescence at 120h, as described in (43).
DSB repair assays
An established strand break rejoining assay using the
plasmid pEGFP-Pem1-Ad2 was used to determine levels
of NHEJ (44). pEGFP-Pem1-Ad2 contains two I-SceI re-
striction enzyme sites, which when digested, generates
Nucleic Acids Research, 2011,Vol.39, No. 17 7467non-compatible DNA ends. Repair by NHEJ results in
the expression of EGFP, which can be quantitated by
ﬂow cytometry relative to a DsRed transfection efﬁciency
control vector. pEGFP-Pem1-Ad2 is incapable of express-
ing EGFP in the absence of repair by NHEJ. An amount
of 6mg I-SceI-linearized pEGFP-Pem1-Ad2 plasmid and
4mg pCMV-DsRed-Express were co-transfected into
1 10
6 immortalized wild-type and Dek knockout MEFs
using Amaxa Nucleofector (Lonza, Allendale, NJ, USA).
pEGFP-Pem1, which does not contain the Ad2 exon
and expresses EGFP, was used as a control for normal-
ization of linearized plasmids. Seventy-twohours post-
transfection, cells were trypsinized, ﬁxed with 2%
paraformaldehyde, resuspended in 3% FBS in PBS and
50000 cells per sample were analyzed by ﬂow cytometry
using a BD LSRII instrument (BD Biosciences) and
FACSDiva software. Data was analyzed by taking the
ratio of total EGFP positive cells to total DsRed positive
cells and normalizing linearized vector samples to pEGFP-
Pem1 controls. A second established assay for DSB repair
via NHEJ was performed according to a previously pub-
lished protocol (45). The construct harbors a 5-bp
microhomology on both sides of the lesion and assesses
DSB end processing and re-ligation by microhomology-
mediated NHEJ. Brieﬂy, wild-type and Dek knockout
MEFs were transfected with DNA plasmid mix (4mgo f
DNA/well, six-well plate), containing a repair plasmid
designed to measure NHEJ and I-SceI expressing vector
(to induce DNA breaks), using Fugene HD (Roche) at
2ml/mg DNA. On the following day, cells were processed
and analyzed by ﬂow cytometric analysis using a BD
FacsCalibur. DSB repair frequency was determined
by calculating the percentage of EGFP positive cells
divided by the percentage of transfection efﬁciency each.
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Figure 1. DEK depletion increases DNA damage markers in vitro and in vivo. (A) U2OS cells were infected with Ad-GFP or AdDEKsh adenovirus
and harvested 3 days post-infection, then analyzed by western blot analysis for DEK, gH2AX, FancD2 and p53
ser15, and quantiﬁed as described in
the ‘Materials and Methods’ section. (B) U2OS cells were infected as in (A) and focus formation was visualized by immunoﬂuorescence on Day 3
post-infection using either gH2AX or FANCD2 primary antibodies together with FITC- or rhodamine-conjugated secondary antibodies. At least ﬁve
ﬁelds and 200 cells, from three independent experiments, were counted for quantiﬁcation of the data, which is presented in the graphs on the right.
Columns, mean values of 200 cells per experiment; bars, SEM; magniﬁcation=100 ; scale bar=10mm. (**P=0.01, ***P=0.0001) (C) Xenografts
generated in nude mice were injected with 10
8 infectious units Ad-GFP or AdDEKsh in the left and right ﬂanks, respectively, three times at 3 day
intervals. Tumors were removed, ﬁxed, and two consecutive sections in each case were subjected to immunoﬂuorescent detection of GFP and
immunohistochemical detection of gH2AX. (D) SAOS-2 cells were infected as in (A) and probed with gH2AX primary and rhodamine-conjugated
secondary antibody, and counterstained with DAPI on Day 4 post-infection. The graphs represent the percentage of cells positive for foci quantitated
on Days 3 and 4 post-infection. Columns, mean values of 200 cells per experiment; bars, SEM; magniﬁcation=100 ; scale bar=10mm. (*P<0.05).
7468 Nucleic Acids Research, 2011,Vol.39, No. 17The statistical signiﬁcance of differences was determined
using two-tailed Wilcoxon matched pairs test.
RESULTS
DEK depletion activates endogenous DNA damage
response pathways
DNA damage was previously shown to occur in HeLa
cells in response to DEK knockdown (18). HeLa cells
harbor human papillomavirus (HPV) sequences
and express the viral oncoproteins E6 and E7, as well as
wild-type p53 which is kept inactive by E6. Since both
oncoproteins modulate DNA damage pathways, we
chose to use HPV-negative, p53 proﬁcient U2OS cells to
rule out the possibility that DNA damage in response to
DEK knockdown is due to HPV. Adenoviral DEK
short hairpin RNA (AdDEKsh) delivery resulted in efﬁ-
cient DEK knockdown and showed an increase in phos-
phorylation of H2AX (gH2AX), as well as an increase in
mono-ubiquitinated FANCD2 by western blot analysis
(Figure 1A). These data were further corroborated by
the appearance of gH2AX, ubiquitinated FANCD2 and
Rad51 foci in DEK depleted cells (Figure 1B and data not
shown), with an  2- to 3-fold increase in the number of
cells containing gH2AX and FancD2 foci compared with
control infected cells. A slight increase in the phosphoryl-
ation of p53 at ser15 was also detected (Figure 1A). We
previously observed that DEK depletion leads to p53
protein stabilization (40). Due to the modest increase of
ser15 phosphorylation observed here, we do not believe
that this modiﬁcation can fully account for p53 stabiliza-
tion. However, a role for other p53 residues that are pho-
sphorylated in response to DNA damage such as ser20
and ser37 is possible. Alternatively, phosphorylation-
independent mechanisms may contribute to p53 accumu-
lation. To determine whether DNA damage occurred in
response to DEK depletion in vivo, we performed human
U2OS tumor xenograft studies in athymic nude mice.
Tumors injected with GFP-tagged AdDEKsh virus ex-
hibited increased levels of gH2AX compared to those
injected with Ad-GFP virus (Figure 1C), suggesting that
DEK depletion is sufﬁcient for the induction of DNA
damage markers in vitro and in vivo.
One prominent feature of apoptotic cells is DNA frag-
mentation, and consequently, the appearance of DSBs. To
exclude the possibility that the appearance of gH2AX foci
in response to DEK depletion was a consequence, rather
than a cause, of apoptosis, we infected SAOS-2 osteosar-
coma cells with AdDEKsh adenovirus to knock down
DEK expression. SAOS-2 cells are genetically deleted for
p53, and do not undergo apoptosis in response to DEK
depletion (40). Similar to the results obtained in U2OS
cells, we observed a signiﬁcant accumulation of gH2AX
foci in DEK-depleted SAOS-2 cells as compared to con-
trols (Figure 1D). Together, these data indicate that the
appearance of DNA damage foci occurs in the absence
of p53 or apoptosis, thus suggestive of a scenario
whereby DEK depletion ﬁrst results in DNA damage
and, subsequently, in p53-dependent cell death.
DEK modulates ATM and DNA-PK activity
Because DEK depletion resulted in the phosphorylation of
H2AX and p53, and the ubiquitination of FANCD2, we
next examined the effect of DEK depletion on DNA
damage response pathways in HeLa cells. Like U2OS
and SAOS-2 cells, HeLa cells exhibited increased DNA
damage upon DEK depletion as observed by increased
levels of DNA strand breaks (Figure 2A). U2OS and
SAOS-2 cells trended towards similar increases
(Supplementary Figure S1). Furthermore, DEK-deﬁcient
HeLa cells exhibited increased gH2AX levels as detected
by western blot analysis (Figure 2B). The phosphorylation
of H2AX in response to DSBs is mediated by the sensor
kinases ATM and DNA-PK. Kinase activation results in
the phosphorylation of a cascade of target proteins and
the recruitment of DNA damage response modulators. To
begin to elucidate whether DEK regulates these kinase-
driven pathways, HeLa cells were infected with Ad-GFP
or AdDEKsh, and treated with etoposide for the time
points indicated to induce DSBs, and analyzed by western
blot analysis. As shown in Figure 2B, DEK-depleted
HeLa cells displayed increased ATM pathway activation
as determined by increased levels of autophosphorylation
of ATM at serine 1981 in both untreated and etoposide-
treated cells (top and bottom panel). Activation of the
ATM pathway was further supported by increased
modest phosphorylation of the ATM target SMC1 in
etoposide treated DEK-deﬁcient cells, when compared to
controls (Figure 2B). Based on the induction of DNA
strand breaks in DEK-depleted human cells (Figure 2A),
it is likely that ATM is indirectly activated by DEK
knockdown via accumulation of DNA damage. Since sig-
niﬁcant ATR kinase activation was not observed in
several experiments (data not shown), these data implicate
ATM kinase activity in the observed increased H2AX
phosphorylation in DEK-deﬁcient human cells.
Interestingly, in contrast to the observed activation of
ATM signaling, DNA-PKcs activity was decreased, as
determined by reduced levels of autophosphorylation at
Ser2056 following etoposide treatment (Figure 2B).
Decreased DNA-PKcs autophosphorylation in response
to DEK knockdown was also observed in g-irradiated
HeLa cells (Figure 2D), in U2OS cells (Figure 2C) and
in Caski cervical cancer cells (data not shown). Overall,
these data suggest that DEK loss results in an increase in
ATM kinase activity and signaling, and a decrease in
DNA-PK activity in response to DSBs.
To determine whether decreased DNA-PKcs phosphor-
ylation in DEK-deﬁcient cells translated into reduced
DNA-PK activity, kinase activities in HeLa cell nuclear
lysates were compared between cells infected with
AdDEKsh and those infected with control adenovirus.
A fragment of p53 that is speciﬁcally phosphorylated by
DNA-PK was utilized as a substrate. Consistent with re-
duced DNA-PKcs autophosphorylation (Figure 2B–D),
DNA-PK kinase activity was compromised in DEK-
depleted cells, as compared to controls (Figure 2E).
Recruitment of the Ku70/80 heterodimer to DSBs is essen-
tial for the formation of the DNA-PK complex and subse-
quent DNA-PKcs autophosphorylation. We therefore
Nucleic Acids Research, 2011,Vol.39, No. 17 7469determined whether DEK depletion affected the mobiliza-
tion of Ku70/80 in etoposide treated cells. Using an estab-
lished immunoﬂuorescence approach, based upon
cell permeabilization prior to ﬁxation, and confocal
microscopy, DEK-deﬁcient cells exhibited impaired
Ku70/80 mobilization when compared to controls
(Figure 3A). Defects in Ku70/80 recruitment to strand
breaks could account for the observed repression of
DNA-PK kinase activity and autophosphorylation in
DEK-deﬁcient cells.
As the ATM and DNA-PK pathways respond to DSBs,
we asked whether DEK itself could relocalize to DNA
damage foci in etoposide treated HeLa cells. DEK foci
were not damage inducible (data not shown).
Additionally, DEK did not colocalize with gH2AX fol-
lowing treatment with etoposide as shown by confocal
microscopy (Figure 3B, left panels). DEK has been
reported to localize to sites of RNA processing at
interchromatin granule clusters (ICGs) in response to
treatment with deacetylase inhibitors (16). When treated
with etoposide, DEK did not colocalize with the splicing
factor SC35, which is concentrated at ICGs (Figure 3B,
right panels). Collectively, these data indicate that while
DEK affects speciﬁc DNA damage signaling responses, it
does not appear to be physically relocated to sites of DNA
damage.
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Figure 2. DEK knockdown leads to increased ATM and decreased DNA-PK signaling. (A) HeLa cells were infected with Ad-GFP and AdDEKsh
adenoviruses. Three days post-infection, cells were collected, suspended in agarose gel, lysed and subjected to electrophoresis for comet assay
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pATM
Ser1981, total ATM, pSMC1
Ser957, total SMC1, pDNA-PKcs
Ser2056 and total DNA-PKcs. (C) U2OS cells were infected as in (A) and treated
with 25mm etoposide for 3h at 3 days post-infection and analyzed for pDNA-PKcs
Ser2056 and total DNA-PKcs by western blot analysis. (D) HeLa
cells were infected as in (A) and treated with 10Gy IR 3 days post-infection, allowed to recover for 3h, and whole cell lysates analyzed by western
blot analysis. Western blots depicted in (C) and (D) are from different parts of the same immunoblot, respectively. (E) HeLa cells were infected with
Ad-GFP or AdDEKsh, and nuclear extracts collected 3 days post-infection. Endogenous DNA was removed from the nuclear extracts by passage
through a DEAE sepharose column, and then kinase assays were performed using a biotinylated DNA-PK speciﬁc p53 target substrate, and activity
determined using a scintillation counter. Columns, mean value of activity of 3 independent experiments; bars, SEM. (*P=0.05, **P=0.02,
***P=0.001).
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Upregulated ATM and suppressed DNA-PK signaling
upon DEK depletion in cancer cell lines indicated that
DEK may regulate DNA damage response and repair
pathways. Since adenoviral DEK shRNA delivery could
potentially inﬂuence DNA damage responses, and since
cancer cells have evolved aberrant responses to damage,
we examined primary MEFs generated from Dek proﬁ-
cient and deﬁcient mice (39). Dek knockout mice were
viable, indicating that DEK is not a necessary requirement
for embryonic development and survival. To examine
murine DNA damage phenotypes in response to genotoxic
agents, we characterized primary MEFs from Dek
knockout, heterozygous or wild-type mice for the detec-
tion of markers of DNA damage. Importantly, BrdU in-
corporation assays demonstrated similar cell-cycle
distributions regardless of DEK presence (Figure 4A).
However, following exposure to low doses of etoposide,
Dek knockout MEFs exhibited decreased cellular growth
compared to controls (Figure 4B), accompanied by an
increase in the number of cells undergoing premature sen-
escence (Figure 4C). Untreated wild-type and knockout
cells grew at similar rates except for a small decrease of
DEK-deﬁcient over wild-type cells on Day 5 when the cells
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Nucleic Acids Research, 2011,Vol.39, No. 17 7471were completely conﬂuent. To rule out differential plating
efﬁciency as a possible contributor for growth differences,
we plated equal cell numbers and quantiﬁed cellular at-
tachment at 4h post-plating. No differences in cellular at-
tachment were noted between wild-type and Dek
knockout cells in the presence or absence of etoposide
(Figure 5D). Clonogenic cellular growth assays, either in
the presence or absence of etoposide, also revealed sub-
stantial defects in Dek knockout MEFs, as compared to
wild-type cells (Supplementary Figure S2). We conclude
that Dek knockout, as compared to wild-type, MEFs are
growth impaired when subjected to genotoxic or other
stress conditions.
DEK knockout MEFs are hyper-sensitive to DNA
damaging agents and deﬁcient in NHEJ
To determine whether MEF stress responses were linked
to the presence of DNA strand breaks, Dek knockout,
heterozygote and wild-type cells were treated with
hydroxyurea (HU) for 24h and subjected to alkaline
comet assay for the direct detection of DNA strand
breaks. Increased frequencies of DNA strand breaks
were observed in Dek heterozygous MEFs, and were
further increased in Dek knockout cells (Figure 5A). The
cells were also subjected to the genotoxic agents hydroxy-
urea, camptothecin and etoposide, and analyzed for
gH2AX levels by western blot analysis. Consistent with
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7472 Nucleic Acids Research, 2011,Vol.39, No. 17the knockdown results in human cancer cell lines, Dek
knockout MEFs exhibited increased baseline levels of
gH2AX compared to the wild-type and heterozygous con-
trols (Figure 5B, left panel, lanes 1, 5 and 9; run separately
in the right panel). Elevated gH2AX levels were also
observed in heterozygous and knockout MEFs compared
to wild-type cells that were treated with DNA damaging
agents (Figure 5B). The slightly higher levels of gH2AX in
etoposide treated heterozygous compared to homozygous
knockout cells were not consistently observed. These data
indicated that loss of DEK function was sufﬁcient to
induce an endogenous DNA damage response, and that
just a 50% reduction in DEK expression could stimulate
cellular DNA damage responses to exogenous stress. The
murine and human DEK proteins share 89% sequence
identity (Supplementary Figure S3). In order to determine
whether retroviral expression of the human DEK protein
can functionally complement Dek-deﬁcient murine cells,
we transduced immortalized Dek knockout MEFs with
a retroviral human DEK expression vector (R780-DEK)
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Dek wild-type, heterozygous, and knockout MEFs and treated with 1mM HU for 24h. Cells were then collected, suspended in agarose gel, lysed and
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Nucleic Acids Research, 2011,Vol.39, No. 17 7473as previously reported for keratinocytes (11). The resulting
control R780 and R780-DEK cell lines were treated with
hydroxyurea, camptothecin and etoposide, and were sub-
jected to DEK and gH2AX speciﬁc western blot analysis
(Figure 5C). DEK expression in Dek knockout MEFs
resulted in a decrease in the phosphorylation of H2AX
in response to each DNA damaging agent (compare
lanes 2 with 6, 3 with 7, and 4 with 8). This indicated
that the human DEK protein can rescue Dek-deﬁcient
murine cells from exaggerated cellular responses to
DNA damage, extending previous ﬁndings by Kappes
et al. from HeLa to murine cells.
Based on the observed defects in DNA-PK activity in
DEK deﬁcient human cells (Figure 2), and similar obser-
vations in MEFs (Supplementary Figure S4), we deter-
mined whether Dek knockout MEFs are deﬁcient for
NHEJ. To this end, we utilized a plasmid-based DNA
repair assay (44). The indicator plasmid
pEGFP-Pem1-Ad2 was linearized with I-SceI to generate
non-compatible DNA ends whose processing and
re-ligation by NHEJ results in intracellular EGFP expres-
sion. Dek knockout and wild-type cells were
co-transfected with linearized template along with a
DsRed plasmid, and repair by NHEJ was quantitated by
ﬂow cytometric detection of EGFP relative to DsRed.
Consistent with decreased DNA-PKcs phosphorylation
and kinase activity in DEK-deﬁcient cells, DNA repair
by NHEJ in the knockout MEFs was signiﬁcantly
reduced in four independent experiments when
compared to wild-type MEFs (Figure 5D). A second
NHEJ reporter assay was utilized that measures the role
of DEK in response to intracellular I-SceI cleavage and
microhomology-mediated NHEJ. Dek wild-type and
knockout MEFs were co-transfected with the reporter
together with an expression vector coding for the I-SceI
endonuclease. Successful repair was detected by EGFP
expression using ﬂow cytometric analysis. Dek knockout
compared to wild-type cells again exhibited a signiﬁcant
decrease in repair by NHEJ (Figure 5E). Together these
data suggest that DEK expression promotes DNA-PK
activity and DNA damage repair by NHEJ.
DISCUSSION
Our previous studies of DEK as an apoptosis inhibitor
have demonstrated that transient DEK depletion leads
to the stabilization of p53 and cell death in HeLa and
primary cells. Unable to detect a direct interaction between
DEK and p53, we examined the possibility that p53 regu-
lation by DEK might be indirect via DNA damage re-
sponses. Indeed, DEK-deﬁcient human and mouse cells
exhibited increased levels of DNA damage, as assessed
by the presence of nuclear DNA repair foci, by western
blot analysis, and by comet assays. This response was in-
dependent of p53 status or apoptosis, occurring in p53
negative SAOS-2 cells which are resistant to apoptosis
induced by DEK knockdown (40). DEK depletion was
previously shown to delay the kinetics of exogenously-
induced DNA damage repair, thus explaining sensitization
of those same cells to DNA damaging agents. Also, DEK
expression conferred chemoresistance to melanocytes in a
manner which was independent of p53 (14). Our data
support this scenario and extend it to murine cells in
which DNA damage was exacerbated in DEK-deﬁcient
cancer cells and primary MEFs. The ﬁnding that
elevated gH2AX levels in Dek knockout MEFs can be
rescued by the expression of human DEK protein
suggests that responsible DEK activities are evolutionarily
conserved between mice and humans. Finally, the induc-
tion of gH2AX foci and apoptosis was not limited to
cultured cells, systems which are inherently prone to
DNA damage and cellular stress conditions (40,46).
DEK depletion in a xenograft tumor model upregulated
the number of gH2AX positive cells in the tumors in vivo,
suggesting that DNA damage induction may underlie
previous observations of cell death in these tumors (39).
The ﬁnding that DEK knockdown is sufﬁcient for gH2AX
induction differs from previously published data (18).
Kappes et al. showed elevated gH2AX levels following
lentiviral DEK knockdown in the presence, but not in
the absence, of genotoxic stress. This difference may be
due to the extent of DEK knockdown which is more
pronounced with adenoviral as compared to lentiviral
shRNA delivery in our hands. Alternatively, small differ-
ences in culture conditions and resulting endogenous
DNA damage levels could be at play. Given that apoptosis
in response to DEK depletion was greatly attenuated in
proliferating primary keratinocytes versus cancer cells
(21,40,47,48), and was not observed in differentiated kera-
tinocytes (11), our data supports the possibility that DEK
might be a target for cancer treatment, perhaps in com-
bination with conventional chemotherapy treatments. The
fact that DEK loss induced DNA strand breaks in
primary MEFs, however, should also raise concerns
about long term DEK inhibition which could conceivably
result in sustained DNA strand breaks, oncogenic muta-
tions and secondary tumorigenesis.
In addition to sensitizing cells to exogenous genotoxic
agents, the loss of DEK was sufﬁcient for causing DNA
strand break accumulation, ATM activity and gH2AX
induction in cancer cells. Together with the established
role of DEK as a chromatin topology modiﬁer, and the
ﬁnding that DEK does not itself re-localize to sites of
DNA damage, it is unlikely that DEK knockdown acti-
vates the ATM response directly, but rather indirectly via
DNA repair dysfunction and subsequent DNA damage
accumulation. Of note, we have neither observed nor
fully excluded a role for ATR in response to DEK loss,
thus leaving open a possible role for DEK in DNA repli-
cation associated DNA damage response pathways. With
regards to DNA repair defects, DEK loss distinctly
decreased the level of Ku70/80 heterodimer recruitment,
DNA-PKcs autophosphorylation, and DNA-PK kinase
activity. Given that Ku70/80 recruitment is a prerequisite
for DNA-PK assembly, detailed studies of the underlying
molecular mechanism by which DEK loss impairs Ku70/
80 recruitment are now critical. Moreover, DNA-PKcs
autophosphorylation at Ser2056 is required for the full
activity of DNA-PK (49,50), and may further impair
DNA-PK function in DEK-deﬁcient cells. Because DEK
regulated DNA damage response pathways, but did not
7474 Nucleic Acids Research, 2011,Vol.39, No. 17itself localize to DNA lesions, we consider it likely that the
observed effects occur via speciﬁc DEK interactions with
chromatin. It is important to note, however, that we
cannot rule out a rapid or transient interaction of DEK
with DSBs. In many cases, DNA repair requires chroma-
tin unpacking prior to repair and chromatin restoration
after repair. Indeed, DEK has been linked to chromatin
topology and functions through preferential binding to
structured DNA and histones and as a histone chaperone
(24,25,34). Mechanisms by which these DEK-chromatin
interactions might be linked to its role in DNA damage
signaling and repair remains to be determined.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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